Hoerni B, Eghbali H, Hoerni-Simon G, Durand M
Oncology. 1982;39(5):292-4. doi: 10.1159/000225654.
16 patients with relapsing non-Hodgkin's malignant lymphomas considered as clinical stage I or II were treated by an association of chemo + radiotherapy and thereafter by maintenance BCG therapy. 5 of them were included in a randomized trial and have a significantly different disease-free survival from patients receiving the same treatment but without BCG. 11 were systematically treated by BCG and they also have a fairly good disease-free survival. Such a treatment appears to be of value in treating these patients and even probably of curing some of them.
16例复发的非霍奇金恶性淋巴瘤患者，临床分期为I期或II期，接受化疗加放疗联合治疗，随后进行卡介苗维持治疗。其中5例纳入随机试验，与接受相同治疗但未用卡介苗的患者相比，无病生存期有显著差异。11例系统性接受卡介苗治疗，他们也有相当好的无病生存期。这种治疗方法在治疗这些患者中似乎有价值，甚至可能治愈其中一些患者。
